U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07937657) titled 'A Study to Evaluate the Safety and Pain Relief of MAX-001 After Surgical Removal of Wisdom Teeth' on Nov. 09.
Brief Summary: This is a single center, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of MAX-001 in participants with post-operative dental pain after wisdom teeth removal.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Impacted Third Molar Tooth
Tooth Extraction Status Nos
Intervention:
DRUG: MAX-001
30 mg oral tablets
DRUG: Placebo
matching placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Maxona Pharmaceuticals, Inc.
Published b...